• Kasi Kiehlbaugh, director of the UArizona Health Sciences Design program, formed AZ Makers Fighting COVID-19, an online group that is coordinating efforts to make face shields and other protective equipment.Read full story on our website, link in profile or: https://bit.ly/34ayqGY
    66 2
    Kasi Kiehlbaugh, director of the UArizona Health Sciences Design program, formed AZ Makers Fighting COVID-19, an online group that is coordinating efforts to make face shields and other protective equipment.Read full story on our website, link in profile or: https://bit.ly/34ayqGY
  • Thank you for all your hard work, dedication and service to the community. Equal thanks goes out to all our allied health professionals and research scientists during this challenging time.
    55 1
    Thank you for all your hard work, dedication and service to the community. Equal thanks goes out to all our allied health professionals and research scientists during this challenging time.
  • The University of Arizona was awarded $147 million in grants from the NIH in 2019, ranking 60th among NIH-funded institutions in the nation. Of that, $128 million was received by the University of Arizona Health Sciences. Read full story on our website, link in profile or: http://bit.ly/3aMRQDR
    52 1
    The University of Arizona was awarded $147 million in grants from the NIH in 2019, ranking 60th among NIH-funded institutions in the nation. Of that, $128 million was received by the University of Arizona Health Sciences. Read full story on our website, link in profile or: http://bit.ly/3aMRQDR
  • Each year, traumatic brain injuries such as concussions cause nearly 2.5 million visits to an emergency room. The most common problem associated with concussions is a headache. Researchers at the #uazmedtucson collaborated in a preclinical study with Teva Biologics and #mayoclinic to identify the cause of post-concussion headaches and a possible therapy for patients who experience this pain each year. The scientists investigated whether a drug that blocks a substance elevated in migraine patients, calcitonin gene-related peptide (CGRP), would alleviate the headache pain by modeling human concussion in mice and assessing post-injury pain sensitivity. Researchers administered the anti-CGRP treatment twice – two hours and then seven days after the injury – and found the two doses significantly reduced pain responses.Read full story on our website, link in profile or: http://bit.ly/32aWtVa
    36 1
    Each year, traumatic brain injuries such as concussions cause nearly 2.5 million visits to an emergency room. The most common problem associated with concussions is a headache. Researchers at the #uazmedtucson collaborated in a preclinical study with Teva Biologics and #mayoclinic to identify the cause of post-concussion headaches and a possible therapy for patients who experience this pain each year. The scientists investigated whether a drug that blocks a substance elevated in migraine patients, calcitonin gene-related peptide (CGRP), would alleviate the headache pain by modeling human concussion in mice and assessing post-injury pain sensitivity. Researchers administered the anti-CGRP treatment twice – two hours and then seven days after the injury – and found the two doses significantly reduced pain responses.Read full story on our website, link in profile or: http://bit.ly/32aWtVa
  • Imagine if you could know the status of any molecule in your body without needing to get your blood drawn. Researchers at the University of Arizona are working on ways to do this by measuring molecules in sweat. When physicians take blood samples from patients, they send the samples to labs to be analyzed for biomarkers. These biological clues indicate everything from cholesterol levels to disease risks, and they can be used to monitor patient health or make diagnostic decisions. The same biomarkers also are found in sweat. Read full story on our website, link in profile or http://bit.ly/39O6pGR
    42 1
    Imagine if you could know the status of any molecule in your body without needing to get your blood drawn. Researchers at the University of Arizona are working on ways to do this by measuring molecules in sweat. When physicians take blood samples from patients, they send the samples to labs to be analyzed for biomarkers. These biological clues indicate everything from cholesterol levels to disease risks, and they can be used to monitor patient health or make diagnostic decisions. The same biomarkers also are found in sweat. Read full story on our website, link in profile or http://bit.ly/39O6pGR
  • A growing concern exists in the fire service about exposure to per- and polyfluoroalkyl substances (PFAS), a group of synthetic, fluorinated chemicals used worldwide since the 1940s. To advance knowledge on exposure to PFAS chemicals and the associated health risks, researchers from @uazpubichealth received a grant from Federal Emergency Management Agency @fema to lead a study of occupational exposures among firefighters. Read full story on our website, link in profile or http://bit.ly/2HjY41j
    40 2
    A growing concern exists in the fire service about exposure to per- and polyfluoroalkyl substances (PFAS), a group of synthetic, fluorinated chemicals used worldwide since the 1940s. To advance knowledge on exposure to PFAS chemicals and the associated health risks, researchers from @uazpubichealth received a grant from Federal Emergency Management Agency @fema to lead a study of occupational exposures among firefighters. Read full story on our website, link in profile or http://bit.ly/2HjY41j
  • A team of UArizona Health Sciences researchers searched for genetic differences between glioblastoma cells from long- and short-term survivors. They found that individuals who survived longer produced a protective protein, which someday might be harnessed to extend survival.Read full story on our website, link in profile or http://bit.ly/2UnI6uQ
    34 1
    A team of UArizona Health Sciences researchers searched for genetic differences between glioblastoma cells from long- and short-term survivors. They found that individuals who survived longer produced a protective protein, which someday might be harnessed to extend survival.Read full story on our website, link in profile or http://bit.ly/2UnI6uQ
  • Therapy that involves exposure to blue light each morning can help in the healing process of people who have suffered mild traumatic brain injuries, such as concussion, researchers at the UArizona Health Sciences have found. Read full story on our website, link in profile or http://bit.ly/2sKKFvL
    45 2
    Therapy that involves exposure to blue light each morning can help in the healing process of people who have suffered mild traumatic brain injuries, such as concussion, researchers at the UArizona Health Sciences have found. Read full story on our website, link in profile or http://bit.ly/2sKKFvL
  • A new research project from the Center for Innovation in Brain Science at the UArizona Health Sciences will seek to identify patient-specific therapeutic targets and evaluate the effectiveness and safety of drug combinations to treat Alzheimer’s disease. Read full story on our website, link in profile or http://bit.ly/2uCDO8c
    33 1
    A new research project from the Center for Innovation in Brain Science at the UArizona Health Sciences will seek to identify patient-specific therapeutic targets and evaluate the effectiveness and safety of drug combinations to treat Alzheimer’s disease. Read full story on our website, link in profile or http://bit.ly/2uCDO8c